As our readers know, investing in marijuana stocks is still considered taboo by some investors.
That can make it difficult to find news and updates on marijuana stocks, since the mainstream media generally avoids covering the cannabis industry because of its taboo status.
However, we know cannabis is more than just a trend. And because the goal of Money Morning is to make investing profitable, we make sure our readers are always up-to-date on the biggest marijuana news that could move the prices of pot stocks.
Entering the month of May, we have 10 marijuana stocks to watch.
| Company | Stock Symbol | Price as of May 1 | YTD Percent Change |
| Scotts Miracle-Gro Co. | SMG | $96.59 | +0.99% |
| Zynebra Pharmaceuticals Inc. | ZYNE | $20.98 | +35.28% |
| Corbus Pharmaceuticals Holdings Inc. | CRBP | $7.20 | +2,566.67% |
| General Cannabis Corp. | CANN | $1.82 | -43.28% |
| Earth Science Tech Inc. | ETST | $0.95 | -59.5% |
| Grow Condos Inc. | GRWC | $0.91 | -24.02% |
| MassRoots Inc. | MSRT | $0.73 | +8.71% |
| VPR Brands LP | VPRB | $0.34 | +17.65% |
| Endexx Corp. | EDXC | $0.07 | +63.62% |
| Advantis Corp. | ADVT | $0.02 | +311.9% |
Here's why these are some of the top pot stocks to watch right now...
10 Marijuana Stocks to Watch Right Now
- Scotts Miracle-Gro Co. (NYSE: SMG) is well-known for its lawn maintenance products, but it's also becoming a well-known name in the marijuana industry. CEO Jim Hagedorn has acquired and invested in companies that specialize in fertilizer for marijuana growers and hydroponic equipment. SMG will report earnings on Tuesday, May 2, 2017, and according FactSet estimates, Scotts is expected to report earnings per share of $2.90 on $1.28 billion in sales.
- Zynerba Pharmaceuticals Inc. (Nasdaq: ZYNE) develops and commercializes synthetic cannabinoid therapeutics. Zynerba's next earnings report is on May 18, 2017, and we are closely watching if the earnings justify an aggressive price target. Analysts who cover ZYNE have a one-year price target of $32.25, which could be a potential profit of 53.71% over the next 12 months.
- Corbus Pharmaceuticals Holdings Inc. (Nasdaq: CRBP) is a pharmaceutical company that develops and commercializes therapeutics to treat fibrotic and inflammatory disease. Like Zynerba, we are closely watching Corbus' next earnings report (May 17, 2017). Analysts who cover CRBP have a one-year price target of $22.25, which could be a profit of more than 210% over the next 12 months.
- General Cannabis Corp. (OTCKMTS: CANN) provides consulting services, financing, and security to marijuana businesses. Right now, General Cannabis is expanding its security division to California, which voted to legalize recreational marijuana in November 2016. According to MMJReporter.com, CANN announced on March 27 it would soon open an office in Sacramento but did not provide an official opening date.
- Earth Science Tech Inc. (OTCMKTS: ETST) is a biotech company that develops dietary supplements for health and alternative medicine markets. On April 11, the company announced it was targeting breast cancer and other women's health issues with its latest CBD-based drug developments and research initiatives. Earth Science's goal is to develop generic pharmaceutical breast cancer and chemo-prevention drugs that are affordable and available to women worldwide.
- Grow Condos Inc. (OTCMKTS: GRWC) purchases, develops, and manages industrial properties across the United States. It offers turnkey grow facilities and is developing cannabis RV parks and destinations. We're watching GRWC closely because it will soon launch the first pot-friendly campground in Oregon, according to Statesman Journal. Grow Condos purchased a five-acre property in March that will be called "Smoke on the Water." According to Oregon Cannabis Connection, the company had a soft opening on April 20, 2017. Eventually, the campground will reportedly have a marijuana dispensary on the property.
- MassRoots Inc. (OTCMKTS: MSRT) is a social media network for cannabis enthusiasts. The company is currently generating a lot of buzz because of a major announcement on April 20. Specifics weren't provided, but the company will partner with Maya Elisabeth (award-winning edibles maker) and Whoopi Goldberg, who own a cannabis company called Whoopi and Maya.
- VPR Brands LP (OTCMKTS: VPRB) is a technology holding company with U.S. and Chinese patents for products like medical marijuana vaporizers. The company recently entered the High Times Cannabis Cup So-Cal, held April 21-23. It finished second in the vape pen cartridges category for its HoneyStick Sub-Ohm Starter Kit, which should bring increased attention to VPR's offerings.
- Endexx Corp. (OTCMKTS: EDXC) offers medical marijuana management services and technology solutions. For example, the company manages patient data and incorporates best patient privacy practices through its technology platform. Endexx CEO Todd Davis recently presented at the Planet MicroCap Showcase, held April 26-28. The three-day conference brought together small- and micro-cap companies with executives, investors, and financial professionals.
- Advantis Corp. (OTCMKTS: ADVT) develops and markets products in the medical cannabis, pharmaceutical, and research sectors. Today, Advantis announced it's receiving increased demand for its premium vape product, Amstercan. According to a press release today (May 1), Chateau Cannabis Co. placed an order that was triple the amount of its first order in March. Nature's Top Shelf ordered 5,000 Amstercans for its first order and is requesting that amount on a monthly basis.
Of course, there are more ways to invest in the marijuana industry than just these 10 stocks.
That's why we want to show you how you can access Money Morning Director of Technology & Venture Capital Research Michael A. Robinson's "bible of weed investing" today...
Your Guide to the Top Marijuana Stocks from Every Ecosystem
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
Michael is one of our most prominent and respected investing "gurus" here at Money Map Press - and for good reason. He is one of the top financial analysts working today. Make no mistake: Michael's ideas are completely his own. He's a true original. He works solely for Money Map Press... and receives absolutely no compensation from companies he writes about.
Which States Will Legalize Marijuana Next?
His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. He's a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style.
Michael's 30-year track record as a leading tech analyst has garnered him rave reviews, too.
As editor of the financial newsletter American Wealth Underground, Michael amassed an amazing track record using rigorous investing. The first analyst to uncover the rare earth mineral crisis, he amassed cumulative gains of 990% for his readers in just 16 months.
His research is world class, too. The Oakland Tribune, Detroit News, The San Francisco Examiner, The Kansas City Times, Wealth Magazine, and American Banker all publish his reporting. He has appeared on Larry King's syndicated radio show.
Robinson has an honors economics degree from the University of Missouri at Columbia with a minor in journalism.
And as a service to Money Morning Members, we're now making available a 90-page cannabis investing guide called The Roadmap to Marijuana Millions.
This "bible of weed investing" reveals the world's top marijuana stocks every serious investor should consider right now.
Normally valued at $499, it can be yours absolutely free. To learn how to get your free copy, click here.
This offer is only available to the first 500 people who respond today. So please go here now to reserve your copy.